Davis P L, Anderson J P, Yamamoto T. "一种的合成方法" [P]. US Patent, US 11848191 B2, 2024-08-22.
发明人陈志强,罗永刚,李文辉. "Method for the Synthesis of 3-(Pyridin-3-yl)-5H-indeno[1,2-c]pyridazin-5-one" [P]. 中国发明专利, 专利号 CN 111635638 B, 授权公告日 2021-07-17.
发明人高志强,孙丽萍,张德明. "A Process for Preparing High-Purity 3-(Pyridin-3-yl)-5H-indeno[1,2-c]pyridazin-5-one" [P]. 中国发明专利, 专利号 CN 108327277 B, 授权公告日 2017-04-26.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2014, 515, (2), 8328-8346.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2024, 1202, (11), 4758-4763.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of 3-(Pyridin-3-yl)-5H-indeno[1,2-c]pyridazin-5-one Using HRMS and NMR". Biomed. Chromatogr., 2013, 663, 7062-7080.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2019, 1369, (8), 5701-5719.